How Cancer Cells Resist Chemotherapy: Design and Development of Drugs Targeting Protein-Protein Interactions
Vadim V Tarasov1, Vladimir N Chubarev1, Ghulam Md Ashraf2
1Sechenov First Moscow State Medical University (Sechenov University), 8-2 Trubetskaya St., Moscow 119991, Russian Federation.
Background:
Resistance toward chemotherapeutics is one of the main obstacles on the way to effective cancer treatment. Personalization of chemotherapy could improve clinical outcome. However, despite preclinical significance, most of the potential markers have failed to reach clinical practice partially due to the inability of numerous studies to estimate the marker's impact on resistance properly.
Objective:
The analysis of drug resistance mechanisms to chemotherapy in cancer cells, and the proposal of study design to identify bona fide markers.
Methods:
A review of relevant papers in the field. A PubMed search with relevant keywords was used to gather the data. An example of a search request: drug resistance AND cancer AND paclitaxel.
Results:
We have described a number of drug resistance mechanisms to various chemotherapeutics, as well as markers to underlie the phenomenon. We also proposed a model of a rational-designed study, which could be useful in determining the most promising potential biomarkers.
Conclusion:
Taking into account the most reasonable biomarkers should dramatically improve clinical outcome by choosing the suitable treatment regimens. However, determining the leading biomarkers, as well as validating of the model, is a work for further investigations.
Insights
Identifying reliable cancer drug resistance markers is crucial for personalized chemotherapy. This study reviews resistance mechanisms and proposes a study design to find effective biomarkers for improved cancer treatment outcomes.
Area of Science:
- Oncology
- Pharmacology
- Biomarker Discovery
Background:
- Chemotherapeutic resistance is a major challenge in cancer treatment.
- Personalized chemotherapy offers potential for improved clinical outcomes.
- Many potential biomarkers fail clinical translation due to inadequate impact assessment.
Purpose of the Study:
- Analyze drug resistance mechanisms in cancer cells.
- Propose a study design to identify reliable biomarkers for drug resistance.
Main Methods:
- Literature review of relevant scientific papers.
- PubMed search using keywords such as 'drug resistance', 'cancer', and 'paclitaxel'.
Main Results:
- Cataloged various drug resistance mechanisms and associated markers.
- Developed a rational study design model for identifying promising biomarkers.
Conclusions:
- Utilizing appropriate biomarkers can significantly enhance treatment efficacy.
- Further research is needed to determine leading biomarkers and validate the proposed study design.
Related Concept Videos
Factors Affecting Protein-Drug Binding: Drug Interactions
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Protein and Protein Structure
A protein's shape is critical to its function. For example, an enzyme...
Protein-protein Interfaces
Factors Affecting Protein-Drug Binding: Protein-Related Factors
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
Design Example: Resistive Touchscreen
When a user touches the screen, the two layers make contact at a specific point known as the touchpoint. This contact reduces the resistance between...


